Content Type: Article

  • ONC Releases Final Rule Implementing Cures Act Information Blocking Prohibition

    ONC Releases Final Rule Implementing Cures Act Information Blocking Prohibition

    ARTICLE / INFORMATION BLOCKING / REPORT

    ONC Releases Final Rule Implementing Cures Act Information Blocking Prohibition

    March 18, 2020

    Read time: 2 min

    Overview

    The Office of the National Coordinator for Health Information Technology (ONC) published its highly anticipated final rule to implement the “information blocking” prohibition of the 21st Century Cures Act by identifying conduct that is not information blocking. ONC’s final rule more closely aligns the information blocking provisions with the HIPAA Privacy Rule’s right of patient access, while maintaining robust limitations on practices by certified health IT developers, health care providers and other regulated actors that are likely to impede the flow of electronic health information. In this Special Alert, we analyze the final rule and suggest practical next steps for regulated actors and their vendors.

    In depth
    Tabs

    James A. Cannatti III

    Partner

    Washington, DC

    Daniel F. Gottlieb

    Partner

    Chicago

    Karen S. Sealander

    Counsel

    Washington, DC

    More insights
    Endnotes

  • INSIGHT: Don’t Fear the Math—Analyzing Layoffs, Plant Closings Under the WARN Act

    ARTICLE

    INSIGHT: Don’t Fear the Math—Analyzing Layoffs, Plant Closings Under the WARN Act

    March 18, 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors
    More insights

  • COVID-19 – Temporary Suspension of the Obligation to File for Insolvency in Germany

    COVID-19 – Temporary Suspension of the Obligation to File for Insolvency in Germany

    ARTICLE / CLIENT ALERT

    COVID-19 – Temporary Suspension of the Obligation to File for Insolvency in Germany

    March 18, 2020

    Read time: 3 min

    Key takeaways
    Overview

    For companies that experience financial difficulties as a result of the Coronavirus (COVID-19) epidemic, the obligation to file for insolvency will be temporarily suspended until September 30, 2020. This was announced by the German Federal Ministry of Justice in a press release on March 16, 2020.

    In depth

    According to the ministry, the draft bill has been prepared, and a first reading in the Bundestag is scheduled for March 25, 2020. It is expected that the law will come into force this month. According to the aforementioned press release, the temporary suspension of the obligation to file for insolvency will be subject to the following conditions:

    1. The occurrence of illiquidity or over-indebtedness results from the effects of the COVID-19 epidemic.
    2. There must be reasonable prospects of a going-concern based on the application for public assistance or serious financing or restructuring negotiations.

    The suspension of the obligation to file for insolvency will therefore be limited to companies that face financial difficulties due to the COVID-19 epidemic. The precise details of the other requirements have not yet been determined. However, a key prerequisite could be that the relevant company has already applied for concrete assistance from the federal government’s financial assistance package. This is indicated in the press release where it states that the suspension of the obligation to file for insolvency is intended to flank the aid measures adopted by the federal government  to support liquidity. It should be avoided that affected companies have to file for insolvency solely because the processing of applications for public assistance, financing or restructuring negotiations  could not be completed in time.

    It is presumed that the exact text of the law will be made public in the March 25 reading in the Bundestag.

    In addition to a suspension of the obligation to file for insolvency pursuant to section 15a InsO, the accompanying regulations on payment prohibitions of the management of a GmbH, AG or GmbH & Co. KG according to § 64 section 1 sentence 1 GmbHG; § 92 section 2 sentence 1 AktG; § 177a in conjunction with § Section 130a para. 1 HGB must be adjusted for clarification purposes.

    Authors

    Dr. Uwe Goetker

    Partner

    Düsseldorf

    Dr. Matthias Kampshoff

    Partner

    Düsseldorf

    More insights

  • H.R. 6201: Families First Coronavirus Response Act

    H.R. 6201: Families First Coronavirus Response Act

    ARTICLE / CLIENT ALERT

    H.R. 6201: Families First Coronavirus Response Act

    March 18, 2020

    Read time: 7 min

    Key takeaways
    Overview

    This legislation has now passed both the House and the Senate and has been enacted into law by the President. The effective date is 15 days after enactment: April 2, 2020.

    In depth

    Executive Summary

    • This legislation applies only to employers who employ less than 500 employees.
    • This legislation is not retroactive; its provisions will apply beginning 15 days after enactment. The legislation is limited to just this coronavirus pandemic; its provisions expire on December 31, 2020.
    • This legislation mandates covered employers provide paid leave for employees affected by the coronavirus if those employees are unable to work or telework. This is being done in two components:
      • Two weeks (80 hours) of paid sick time at the employee’s full regular rate of pay, subject to dollar caps; this is reduced to two-thirds pay if the leave is due to caring for others (e., a sick or quarantined family member or a child whose school is closed or whose childcare provider is unavailable due to the coronavirus).
      • Ten additional weeks of FMLA leave but only for those who must stay at home to care for a child whose school is closed; these 10 weeks will be paid at two-thirds the employee’s regular rate of pay, again subject to dollar caps.
    • This legislation provides payroll tax credits to offset all costs of providing these paid leaves.
    • Other proposals concerning cash payments to every American; tax relief; and other stimulus provisions for the economy are still under consideration in Congress.

    Practical Implications

    For employers who employ less than 500 employees, this law can impose monetary burdens. Because the credit is only realized when the payroll tax is paid, there may be cash flow concerns for certain employers. Additionally, because the initial two work weeks of emergency paid sick leave covers not only employees who have COVID-19 or are suspected to have COVID-19 but also employees subject to a quarantine or isolation order, this benefit could possibly be used by a broad swath of employees as more states and cities consider such isolation orders. Regardless of financial impact, there is also an administrative burden: covered employers must adjust their policies to comply, including communicating the specifics of the new policies to your employees.

    For employers who employ more than 500 employees, this legislation just does not apply.

    In More Detail

    The Emergency Paid Sick Leave Act section of this legislation requires two weeks of paid sick leave (80 hours or the amount of hours a part-time employee works over a two week period). This emergency paid sick leave is to be available for use immediately, no matter how long the employee has been employed.

    It must be made available in addition to any paid sick leave an employer might already provide on its own or as required by local or state law. This paid sick leave does not create a requirement to pay for unused emergency paid sick leave upon termination. Further, it does not apply retroactively.

    This paid sick leave may be used when an employee is unable to either work or telework for any of the following reasons:

    1. The employee is subject to a government quarantine or isolation order related to COVID-19;
    2. The employee has been advised by a healthcare provider to self-quarantine due to COVID-19;
    3. The employee has symptoms of COVID-19 and is seeking a medical diagnosis;
    4. The employee is caring for an individual subject to either (1) or (2);
    5. The employee needs to care for a child whose school or place of care is closed or whose childcare provider is unavailable due to coronavirus;
    6. The employee is experiencing any other substantially similar condition specified by the Secretary of Health and Human Services.

    This sick leave is paid at the employee’s regular rate of pay if it is used for purposes (1), (2) or (3). That pay, however, is capped at $511 per day and $5,110 in total, corresponding to the caps on tax credits provided to offset the costs of this mandated paid sick leave.

    For employees who use this leave for purposes (4), (5) and (6), the benefit is to be provided at two-thirds the employee’s regular rate of pay. This too is capped, but at $200 per day and $2,000 total, again corresponding to the caps on the tax credits.

    There are no certification requirements. But, an employer may require an employee to follow reasonable notice procedures following the first workday (or portion thereof) when an employee opts to take this paid sick leave. An employer cannot require the employee utilizing the leave to search for or find a replacement employee to cover the hours missed.

    An employer may not discipline, discharge or discriminate in any other manner against an employee who takes this paid sick leave. Failure to provide this paid leave could subject the employer to requirements to pay both back pay and statutory damages equal to the amount of back pay.

    Eventually, there may eventually be regulations from the Department of Labor excepting businesses with less than 50 employees. Immediately, however, there is only a healthcare employer exception: an “employer of an employee who is a health care provider or an emergency responder may elect to exclude such employee” from this pandemic-emergency FMLA leave altogether.

    The Emergency Family and Medical Leave Expansion Act section of this legislation adds “qualifying need related to a public health emergency” as a ground for FMLA leave. But, unlike traditional FMLA (which is unpaid), leaves under this exception will be paid after the first 10 days. This paid FMLA leave is only applicable to employers with 500 employees or less and only applies to the leave for a “qualifying need related to a public health emergency.”

    Practically, a qualifying employee will utilize the two weeks (80 hours) of paid sick leave provided by the Emergency Paid Sick Leave Act. For the remainder of the 12 weeks of FMLA, the employer must provide paid leave at two-thirds the employee’s regular rate of pay. This is capped at $200 per day and $10,000 total, which corresponds to the caps on the tax credits provided to offset the costs of this legislation.

    A “qualifying need related to a public health emergency” is narrowly defined: it covers only an employee who is unable to work (or telework) due to a need to care for a child under 18 years of age because the child’s school or place of care has been closed or because the childcare provider is unavailable due to “an emergency with respect to COVID-19 declared by a Federal, state, or local authority.”

    For this leave, a qualifying employee is any employee who has been employed for more 30 days. In any case where the necessity of this leave is reasonably foreseeable, an employee shall provide the employer with notice of that leave. There are, however, no certification provisions. Further, paid leave is not available retroactively.

    Eventually, there may be regulations from the Department of Labor excepting businesses with less than 50 employees. Immediately, however, there is only a healthcare employer exception: an “employer of an employee who is a health care provider or an emergency responder may elect to exclude such employee” from this pandemic-emergency FMLA leave altogether.

    Tax credits will be allowed to offset anticipated costs for both this paid FMLA leave and this emergency paid sick leave. Employers are allowed a credit against the employer portion of Social Security taxes equal to 100% of the qualified paid FMLA leave and paid emergency sick leave mandated by this law that is paid during each calendar quarter.

    Authors

    Barrick Bollman

    Partner

    Chicago

    More insights

  • DEA: In-Person Visit Not Required for Controlled Substances Prescription During Public Health Emergency

    DEA: In-Person Visit Not Required for Controlled Substances Prescription During Public Health Emergency

    ARTICLE / CLIENT ALERT

    DEA: In-Person Visit Not Required for Controlled Substances Prescription During Public Health Emergency

    March 18, 2020

    Read time: 4 min

    Key takeaways
    Overview

    The US Drug Enforcement Administration (DEA) stated in an FAQ on its website that prescribers may issue prescriptions for controlled substances based on a telemedicine encounter in the absence of an in-person medical evaluation for the duration of the COVID-19 public health emergency. This alert reviews the FAQ and the state level barriers that remain for the exception.

    In depth

    The US Drug Enforcement Administration (DEA) stated in an FAQ on its website that for the duration of the public health emergency declared by US Department of Health and Human Services (HHS) Secretary Alex M. Azar with regard to COVID-19, prescribers may issue prescriptions for controlled substances based on a telemedicine encounter in the absence of an in-person medical evaluation. This development could remove a significant barrier to the use of telemedicine in the treatment of patients affected by the COVID-19 outbreak and other vulnerable populations. State barriers to such practice may still exist, however, and the full effect of the exception may require certain state governments to follow suit.

    Background

    The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 requires a telemedicine provider to perform an in-person medical evaluation of a patient prior to prescribing a controlled substance to that patient, unless an exception applies. As noted in the DEA FAQ, one such exception occurs when the secretary of HHS has declared a public health emergency (Public Health Emergency Exception), such as the declaration by Secretary Azar with regard to COVID-19 on January 31, 2020, with retroactive effect to January 27, 2020.

    The DEA FAQ states that as a result of the declaration, DEA-registered practitioners may issue prescriptions for controlled substances to patients for whom they have not conducted an in-person medical evaluation, provided:

    • The prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of her professional practice.
    • The telemedicine communication is conducted using an audio-visual, real-time, two-way interactive communication system.
    • The practitioner is acting in accordance with applicable federal and state law.

    The DEA FAQ generally aligns with the requirements of the Ryan Haight Act.

    Don’t Forget State Law

    While the Ryan Haight Act is often the focus of telemedicine remote prescribing compliance, in reality remote prescribing regulation is largely left to the states. Remote prescribing restrictions can be commonly found in telemedicine-specific statutes or regulations, pharmacy practice acts, medical practice acts, and in controlled substances acts themselves. Some states still require a face-to-face encounter prior to prescribing controlled substances to treat a patient. As a result, the scope of the exception could be limited within a particular state by the application of state laws that are more stringent than the exception with respect to the prescription of controlled substances based on a telemedicine encounter.

    While some states have relaxed prohibitions against prescribing controlled substances based on a telemedicine encounter, others have limited the practice to patients in certain treatment facilities or with certain conditions, such as substance abuse disorders. States may also continue to enforce additional restrictions on prescribers, particularly with respect to cross-border practices, including limitations with respect to the licensure or registration of prescribers qualified to prescribe controlled substances.

    Certain recent COVID-19 state emergency declarations may loosen state remote prescribing requirements. For example, the Mississippi State Board of Medical Licensure issued a proclamation on March 14, 2020, stating that the board will not enforce any statute, rule or regulation that requires physicians to personally examine patients before issuing a prescription, including controlled substances.

    Before changing current telemedicine prescribing practices based on the DEA FAQ, prescribers should review any state law restrictions on prescribing controlled substances to patients seen via telemedicine without a prior physical examination.

    Authors

    Amanda Enyeart

    Partner

    Chicago

    Marshall E. Jackson , Jr.

    Partner

    Washington, DC

    Lisa Mazur

    Partner

    Chicago

    More insights

  • How to Handle Elective Surgeries and Procedures During the COVID-19 Pandemic

    How to Handle Elective Surgeries and Procedures During the COVID-19 Pandemic

    ARTICLE / CLIENT ALERT

    How to Handle Elective Surgeries and Procedures During the COVID-19 Pandemic

    March 22, 2020

    Read time: 13 min

    Key takeaways
    Overview

    Government officials and hospital, medical and dental associations have issued guidance and statements regarding whether to continue performing elective surgeries in light of the Coronavirus (COVID-19) pandemic. Some authorities have recommended ceasing all elective surgeries until the transmission of COVID-19 has slowed. Others believe that the decision should be made on a case-by-case basis, taking into account a patient’s prognosis without the procedure.

     

    In depth

    UPDATED MARCH 22, 2020

    Timeline of Recommendations Regarding Elective Surgeries and Procedures

    On March 1, 2020, the Centers for Disease Control and Prevention (CDC) issued Interim Guidance for Healthcare Facilities: Preparing for Community Transmission of COVID-19 in the United States. The CDC recommended that inpatient facilities reschedule elective surgeries as necessary and shift elective urgent inpatient diagnostic and surgical procedures to outpatient settings, when feasible.

    On March 13, 2020, the American College of Surgeons (ACS) released COVID-19: Recommendations for Management of Elective Surgical Procedures, and recommended minimizing, postponing or canceling electively scheduled surgeries and invasive procedures. ACS stated: “Each hospital, health system, and surgeon should thoughtfully review all scheduled elective procedures with a plan to minimize, postpone, or cancel electively scheduled operations, endoscopies, or other invasive procedures until we have passed the predicted inflection point in the exposure graph and can be confident that our health care infrastructure can support a potentially rapid and overwhelming uptick in critical patient care needs.”

    On March 14, 2020, US Surgeon General Jerome Adams, MD, retweeted ACS’s guidance, urging hospital and healthcare systems to “please consider stopping elective procedures until we can” flatten the curve. The surgeon general explained that each elective surgery performed potentially brings COVID-19 to these facilities, depletes personal protective equipment (e.g., gloves, masks, goggles, gowns) stock, and taxes personnel who may be needed for COVID-19 response.

    On March 15, 2020, in response to these recommendations, the American Hospital Association, Association of American Medical Colleges, Children’s Hospital Association and Federation of American Hospitals sent a letter to the surgeon general requesting that he clarify his comments by recognizing the gradients of elective surgeries and offering guidance on how to classify the various levels of necessary care. The associations explained that “elective” simply means that “a procedure is scheduled rather than a response to an emergency,” and could therefore include, for example, replacement of a faulty heart valve, removal of a serious cancerous tumor or a pediatric hernia repair. The associations stated that the delay or cancellation of these procedures often rapidly worsens the patient’s condition, potentially turning it into a life-threatening condition and making the patient more vulnerable to COVID-19. The associations recommended that physicians determine what is in the patient’s best interest and make a case-by-case evaluation of many factors, such as the current and projected COVID-19 cases in the facility and in the surrounding area, and the urgency of the procedure.

    On March 16, 2020:

    • The Ambulatory Surgery Center Association released a position statement regarding its stance on elective surgeries during the COVID-19 pandemic in which it stated that “ASCs can continue to provide safe surgical care for patients whose condition cannot wait until the health care system returns to normal operations.”
    • The American Dental Association issued a news alert recommending that dentists nationwide postpone elective procedures for the next three weeks.
    • The American Academy of Ophthalmology issued a news alert supporting ACS’s recommendation to minimize, postpone or cancel elective surgeries while recognizing that the timing may vary by community and disease indication.

    In a March 17, 2020, White House Coronavirus Task Force press briefing, White House COVID-19 response coordinator Dr. Deborah Birx recommended that hospitals and dentists cancel all elective surgeries over the next two weeks in order to free up hospital beds and space. The task force has stated that its recommendations are not mandatory.

    In a March 17, 2020, White House Coronavirus Task Force press briefing, White House COVID-19 response coordinator Dr. Deborah Birx recommended that hospitals and dentists cancel all elective surgeries over the next two weeks in order to free up hospital beds and space. The task force has stated that its recommendations are not mandatory.

    On March 18, 2020, the Centers for Medicare & Medicaid Services (CMS) released recommendations to conserve personal protective equipment, beds and ventilators and limit the exposure of patients and staff to COVID-19. CMS recommended that all non-essential dental exams and procedures be postponed until further notice. CMS also recommended postponing or canceling non-essential adult elective surgery and medical and surgical procedures, and making case-by-case evaluations on whether a planned surgery should proceed. CMS suggested considering a number of factors, such as the patient’s health and age and the urgency of the procedure. CMS also provided examples of surgeries and procedures that would be appropriate to delay and others that would be permissible to continue to perform.

    On March 19, 2020, the ASCA released new guidance for ambulatory surgery centers (ASCs) with respect to what might constitute a “necessary surgery” during the COVID-19 pandemic. The guidance states that “[a] surgery may be deemed urgent and necessary if the treating physician decides that a months-long delay would increase the likelihood of significantly worse morbidity or prognosis for the patient,” and provides examples of cases that might still need to proceed with surgery during the COVID-19 pandemic.

    The ASCA noted that ASCs should be prepared in case hospitals need to shift necessary surgeries to ASCs or ASC resources otherwise become necessary to support community efforts to address the COVID-19 pandemic. The ASCA cautioned that the effects of the COVID-19 pandemic could create situations in which ASCs must temporarily suspend services, such as when an individual who has been in an ASC facility is suspected or diagnosed with COVID-19, or when a significant shortage of personal protective equipment prevents the safe practice of surgical cases. In addition to providing this guidance, the ASCA is tracking state activity affecting ASCs.

    On March 20, 2020, the ASCA released a message to ASCs instructing them to strictly adhere to federal and state guidance to immediately postpone all surgeries that can be delayed for six to eight weeks and to use personal protective equipment sparsely and wisely. The ASCA encouraged all ASCs to communicate with their local hospitals to ensure a coordinated response in the best interest of their communities.

    Hospital and Local Leader Response

    In light of these recommendations, several hospitals and health systems have announced that they will postpone elective surgeries and procedures, although the timeframes for postponement vary. Other hospitals are making decisions on a case-by-case basis.

    Additionally, several state governors and public health departments have recommended that elective surgeries and procedures be postponed or cancelled:

    • On March 15, 2020, Massachusetts Department of Public Health (DPH) Commissioner Monica Bharel signed an order directing all hospitals and ambulatory surgical centers to implement procedures published by the DPH regarding the scheduling, cancelation and performance of non-essential, elective invasive procedures until the state of emergency is terminated. DPH recommended that providers at each hospital or ambulatory surgical center use their clinical judgment on a case-by-case basis for any invasive procedures necessary to preserve the patient’s life and health. This recommendation does not apply to the cancellation or delay of life-sustaining care. DPH defined non-essential, elective invasive procedures as procedures that are scheduled in advance because they do not involve a medical emergency (terminating a pregnancy is not considered a non-essential, elective invasive procedure for the purpose of this guidance). However, the ultimate decision should be based on clinical judgment by the caring physician. The DPH procedures list examples of non-essential, elective invasive procedures.
    • On March 16, 2020, New York Mayor Bill De Blasio signed an executive order that directed all hospitals and ambulatory surgery centers in New York City to cancel or postpone all elective surgeries that may be cancelled or postponed based on patient risk starting March 20, 2020. The goal is to make additional hospital beds available so that the health system is not overwhelmed during a potential spike in COVID-19 cases, while also limiting exposure of healthy individuals to COVID-19.
    • On March 17, 2020, Director of the Ohio Department of Health, Amy Acton, issued a director’s order stating that all non-essential or elective surgeries and procedures that utilize PPE should not be conducted. Acton defined a non-essential surgery as a procedure that can be delayed without undue risk to the current or future health of a patient.
    • On March 19, 2020;
      • Alabama Governor Kay Ivey issued a statement that “all elective dental and medical procedures shall be delayed, effective immediately.”
      • Colorado Governor Jared Polis issued an executive order suspending, effective March 23, 2020, all voluntary or elective surgeries or procedures, whether medical, dental or veterinary, until April 14, 2020, unless extended further. The order states that a voluntary or elective surgery or procedure means that the surgery can be delayed for a minimum of three months without undue risk to the current or future health of the patient as determined by the guidelines developed by the hospital, surgical center or other treating medical facility. The order sets forth four situations in which a surgery or procedure may proceed. Rural and critical access hospitals are exempt from this order but are strongly advised to comply on a voluntary basis.
      • Washington Governor Jay Inslee signed a proclamation restricting non-urgent medical and dental procedures, effective immediately until May 18, 2020. The proclamation prohibits “all hospitals; ambulatory surgical facilities; and dental, orthodontic and endodontic offices in Washington state from providing healthcare services, procedures and surgeries that, if delayed, are not anticipated to cause harm to the patient within the next three months, with exceptions and as provided below. This does not include outpatient visits delivered in hospital-based clinics.” The proclamation provides a list of examples of procedures to delay. The order does not apply to the full suite of family planning services and procedures or to treatment for patients with emergency/urgent needs. Hospitals and ambulatory surgical facilities may perform any surgery that if delayed or canceled would result in the patient’s condition worsening.
    • On March 20, 2020:
      • Florida Governor Ron DeSantis signed an executive order, which, effective immediately, prohibited the provision of any “medically unnecessary, non-urgent or non-emergency procedure or surgery which, if delayed, does not place a patient’s immediate health, safety, or wellbeing at risk, or will, if delayed, not contribute to the worsening of a serious or life-threatening medical condition.” The order applies to all hospitals; ambulatory surgical centers; office surgery centers; dental, orthodontic and endodontic offices; and other healthcare practitioners’ offices in Florida. The order incorporates much of CMS’s March 18 recommendations regarding the limitation of all non-essential surgeries and procedures. The order will remain in effect until the expiration of the governor’s prior order declaring a state of emergency for Florida due to the COVID-19 outbreak.
      • Michigan Governor Gretchen Whitmer signed an executive order requiring all hospitals, freestanding surgical outpatient facilities, dental facilities and state-operated outpatient facilities to implement a plan to temporarily postpone all non-essential procedures by March 21, 2020, and continuing while the state of emergency declared is in effect. The order defines “non-essential procedure” as a medical or dental procedure that is not necessary to address a medical emergency or to preserve the health and safety of a patient, as determined by a licensed medical provider. The order includes a list of medical procedures and dental procedures that must be postponed and those that may continue to be performed. The order specifies that emergency or trauma-related procedures where postponement would significantly affect the health, safety and welfare of the patient must not be postponed.
      • Vermont Governor Phil Scott signed an executive order directing all clinicians to expedite postponement of all non-essential adult elective surgery and medical and surgical procedures, including all dental procedures, in the safest and most expedient way possible, effective immediately until April 15, 2020, unless extended. The order states that case-by-case evaluations on whether a planned surgery or procedure should proceed will be made by clinicians, and lists several factors for them to consider.

    Considerations

    Elective surgeries and procedures often make up a significant percentage of healthcare provider revenue. Postponing these procedures will undoubtedly have significant financial ramifications for virtually all providers, from hospitals and health systems to physician and dental practices. While the CMS recommendations are not yet mandatory, a number of states have taken them to the next level by mandating that elective procedures be put on hold to try to preserve limited resources within the healthcare system and mitigate community spread of COVID-19. Other states will likely continue to follow suit, as the COVID-19 pandemic stresses the healthcare systems in additional states throughout the country. These orders are necessarily being put together hastily against the backdrop of a pandemic, resulting in key questions for which there is little available guidance to follow. For instance, where exactly is the line drawn for what constitutes non-essential procedures, and when does a procedure become urgent? Providers are left to navigate this uncertainty and make judgment calls that will affect their patients and their already-imperiled bottom lines. Another consideration worth noting is that, to the extent non-hospital providers such as physician practices begin to limit their hours and accessibility due to government recommendations and dwindling demand for non-essential procedures, additional stress could be placed on hospitals as patients’ options for care become more limited.

    Cancelled elective surgeries may also affect participation in payment models sponsored by Medicare and other payors, which may cause further financial stress. Hundreds of institutions across the country participate in inpatient episode-of-care models such as the Comprehensive Care for Joint Replacement Model or the Advanced Bundled Payments for Care Improvement Model. These episode-based payment models reward institutions for maintaining costs below set target prices and maintaining or improving quality of care. Disruptions in a participant’s ability to provide these services, or changes to the typical resources necessary to provide these services, may not only affect performance in the current model year, but may also impact future years because of the use of historical claims data to set target prices for episodes in future years.

    In addition to loss of revenues, many providers, particularly hospitals and health systems, face increased costs associated with the COVID-19 pandemic, including locating and purchasing additional—and often more expensive—supplies and equipment, higher staffing levels, additional paid sick leave and paid time off for employees, enhanced training on telehealth, and setting up additional separate testing sites for COVID-19, among other extraordinary expenses. Hospitals treating patients with COVID-19 also face uncertain reimbursement. Moreover, for all providers, it is unclear when cancelled surgeries could be rescheduled, as the United States is still working to flatten the curve of the pandemic. We do not yet know when the curve will begin to flatten, reflecting containment of the virus. These steps, while necessary from a public health perspective, leave providers in a tenuous position.

    As providers find themselves in the crosshairs of the COVID-19 crisis, they may simultaneously find themselves in a challenging fiscal situation with continued uncertainty ahead. As law and policy makers seek to provide economic and regulatory relief to affected industries, it will be important for hospitals and other providers to document the impact of COVID-19 on their operations and their bottom line, and to communicate this information and any needed regulatory relief to their elected officials, their trade and professional associations, and their government relations advisors. Providers should also continue to evaluate their options and obligations with respect to how they conduct themselves and address their patients’ needs as new guidance and additional orders are issued as the COVID-19 crisis evolves in real time.

    Shelia Madhani of McDermott+Consulting also contributed to this On the Subject.

    Authors

    Karen S. Sealander

    Counsel

    Washington, DC

    Dana Dombey

    Partner

    Miami

    Adam J. Rogers

    Partner

    Miami

    More insights

  • Coronavirus FAQs for US Employers

    ARTICLE

    Coronavirus FAQs for US Employers

    March 18, 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors
    More insights

  • The Tax Impact of Recent Federal Actions Relating to COVID-19

    The Tax Impact of Recent Federal Actions Relating to COVID-19

    ARTICLE / CLIENT ALERT

    The Tax Impact of Recent Federal Actions Relating to COVID-19

    March 18, 2020

    Read time: 4 min

    Key takeaways
    Overview

    The Federal government has recently taken a series of actions concerning the novel coronavirus disease (COVID-19). We discuss the tax implications of these decisions.

    In depth

    On March 13, 2020, President Trump signed a Proclamation on Declaring a National Emergency Concerning the Novel Coronavirus Disease (COVID-19) Outbreak under the Robert T. Stafford Disaster Relief and Emergency Assistance Act (the “Stafford Act”).

    By invoking the Stafford Act, the President provides the Internal Revenue Service (IRS) and US Department of the Treasury (the “Treasury”) significant authority to offer tax relief to those in federally designated disaster areas. While it is not uncommon for a state or locality to be designated as an emergency or disaster area, the severity of the COVID-19 outbreak has required a national response. The President’s declaration has led the Federal Emergency Management Agency (FEMA) to declare an emergency in every state, territory and certain tribal lands. A list of each declaration is available on FEMA’s website and will be updated as more specific forms of relief are authorized.

    After FEMA has designated an area as an emergency or disaster area, federal agencies may approve forms of individual and public assistance. The Internal Revenue Code (“Code”) provides the IRS unique discretion in a “federally declared disaster.” A federally declared disaster includes any disaster subsequently determined by the President to warrant assistance under the Stafford Act. Code Sections 7508A and 139 are the primary provisions regarding disasters, although several other provisions may also be invoked. These provisions should be effective provided the COVID-19 emergency constitutes a disaster within the meaning of the Code. Code Section 7508A allows the IRS to extend tax return filing deadlines, extend tax payment deadlines, and waive penalty and interest charges for individuals impacted by a disaster. Treasury Secretary Steven Mnuchin appears to have exercised this authority on March 17, 2020, by authorizing the deferral of up to $1 million in tax payments for individuals and $10 million for corporations without incurring penalties or interest charges. Code Section 139 excludes qualified disaster relief payments from a taxpayer’s gross income. Qualified disaster relief payments include reimbursement for reasonable and necessary personal, family, living or funeral expenses incurred because of a disaster, as well as payments by state and local governments in order to promote the general welfare. The legislative history indicates they do not include payments in the form of income replacement. Further, Rev. Rul. 2003-12 clarified that otherwise eligible payments made by an employer to their employees could qualify under Section 139. Employers may be able to deduct assistance payments as ordinary and necessary business expenses.

    A day after the President’s declaration, the House of Representatives passed H.R. 6201: Families First Coronavirus Response Act. The current text of the bill would provide tax credits for paid sick and paid family and medical leave.

    Practice Point: Much of the impact of the President’s declaration, particularly under Code Section 7508A, can only be determined after the IRS and the Treasury decide how to utilize their discretion. However, if their employees are impacted by COVID-19, employers may wish to evaluate whether their planned assistance qualifies under Section 139 and thus will not result in their employees recognizing any unanticipated gross income.

    Authors
    More insights

  • Key Compensation Committee Priorities at Tax-Exempt Orgs

    ARTICLE

    Key Compensation Committee Priorities at Tax-Exempt Orgs

    March 18, 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors
    More insights

  • UK Update: Guidance for FCA-Regulated Managers (COVID-19)

    UK Update: Guidance for FCA-Regulated Managers (COVID-19)

    ARTICLE / CLIENT ALERT

    UK Update: Guidance for FCA-Regulated Managers (COVID-19)

    18 March 2020

    Read time: 6 min

    Key takeaways
    Overview

    Our previous publications and Alerts discussed various considerations that hedge fund managers and private equity sponsors generally should take into account when preparing for business interruptions that may be associated with the coronavirus outbreak. The following additional considerations will apply to managers that are headquartered in the United Kingdom or have group affiliates regulated by the UK Financial Conduct Authority (“FCA”). These considerations apply to all FCA-authorised firms to which they are relevant, irrespective of their regulatory permissions.

    Operational Resilience

    The FCA, Bank of England and HM Treasury recently published a supervisory statement addressing the developments relating to the spread of COVID-19. This statement made it clear that firms were expected to continue to comply with their ongoing regulatory requirements despite market volatility and irrespective of the business disruption meaning that many managers have implemented certain aspects of their business continuity plans (“BCPs”).

    In another statement published on 17 March 2020, the FCA again highlighted the importance of operational resilience. Firms must have contingency plans to deal with major events and the regulator expects these plans to have been tested. The FCA and PRA continue their work on the rules aimed at strengthening operational resilience of UK firms proposed in CP19/32.

    Given the recent market volatility, managers should be vigilant in challenging the assumptions that underpin their BCPs, as certain contingencies may need to be adapted as the spread of COVID-19 continues. The FCA has indicated that they intend to engage with a wide range of firms to review their BCPs in the near term. Managers should use this warning as an impetus to document their review and stress-test their BCPs.

    Compliance with Telephone-Recording Obligations

    Managers should ensure they can continue to record and monitor relevant communications if staff works from home or at alternative sites. Managers that currently do not record mobile communications should consider providing key employees with recording software or equipment as part of their BCPs. Managers who are unable to comply with the telephone recording requirements need to notify the FCA.

    Transactions and Orders

    The FCA has not so far offered any relief or forbearance with regards to compliance with record-keeping or transaction reporting obligations, although it has promised to work with trade associations, industry bodies and firms to resolve any issues as they come up. In the meanwhile, managers are expected to continue entering orders and transactions promptly into the relevant trading systems, and maintain full records of orders and transactions. As managers are moving to alternative sites and work from home arrangements, they must not lose sight of the broader control environment for trading and operations. For example, when reviewing their BCP arrangements, firms should separately consider the increased risk of trade errors where a remote working policy has been implemented.

    Trading Surveillance

    Managers must still take all steps to prevent market abuse. This could include enhanced monitoring or retrospective reviews. The market surveillance teams at the FCA continue to monitor for market abuse and other misconduct and firms are still receiving information requests relating to their trading activities. These must be responded to on a timely basis.

    Regulatory Reporting

    Firms should assume that the usual reporting deadlines will apply. If a firm is experiencing difficulties in submitting their regulatory data, the FCA expects the firm to maintain appropriate records during the relevant period and submit the data as soon as possible. Firms are advised against delaying their filings unnecessarily, and should contact the FCA if they are not able to comply.

    Outsourcing

    Managers that rely on third-party service providers for performance of material functions will need to engage with them to ensure these business services will not suffer interruptions. Managers should review service provider contracts for any “material adverse change” or “force majeure” clauses, obtain the necessary service continuity assurances from service providers, and take these matters into account when stress-testing their business continuity and disaster recovery scenarios. Irrespective of any outsourcing, responsibility remains with the regulated manager.

    Access to Compliance Support

    Managers must ensure that trading and other personnel are able to access the compliance function (and vice versa) even where they have implemented a remote working policy. Personnel should be briefed on all arrangements and systems for communications with others within the firm and provided with emergency contact details for key persons within the firm. Managers will need to review the legal basis on which personal data is being shared and should look to update internal data protection policies (e.g., employee privacy notices) where necessary.

    Temporary Trading Restrictions

    Firms should keep regulatory announcements relating to emergency measures, such as short-selling bans, position limits, market suspensions and position disclosure obligations, under constant review. In particular, firms are advised to monitor the FCA’s news page and ESMA’s press-release page, as well as the websites of other regulators, and any updates circulated by their brokers and counterparties in the relevant markets. Managers should ensure that staff or external service providers are on standby to make modifications to their portfolio/execution management systems (e.g., automated tracking of positions) to ensure compliance with such emergency measures.

    Managers should also review their trading documentation and exchange rules, and stress-test the impact of scenarios involving market interruptions on their portfolios.

    Authored by Josh Dambacher, Christopher Hilditch and Anna Maleva-Otto.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    This communication is issued by Schulte Roth & Zabel LLP and Schulte Roth & Zabel International LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP and Schulte Roth & Zabel International LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Josh Dambacher

    Partner

    London – One Eagle Place

    Christopher Hilditch

    Partner

    London – One Eagle Place

    More insights